Livia Casciola-Rosen Selected Research

Rheumatoid Arthritis

1/2021	Autoantibodies targeting telomere-associated proteins in systemic sclerosis.
8/2013	Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.
7/2008	Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Livia Casciola-Rosen Research Topics

Disease

32	Myositis (Idiopathic Inflammatory Myopathies) 10/2023 - 09/2002
31	Dermatomyositis (Dermatopolymyositis) 10/2023 - 09/2002
31	Neoplasms (Cancer) 10/2023 - 10/2003
12	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023 - 06/2009
11	Rheumatic Diseases (Rheumatism) 01/2023 - 07/2008
10	Systemic Scleroderma (Systemic Sclerosis) 11/2023 - 07/2002
9	Muscular Diseases (Myopathy) 01/2023 - 09/2010
9	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 10/2003
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2007
7	Melanoma (Melanoma, Malignant) 05/2022 - 07/2011
4	Calcinosis 11/2023 - 07/2014
3	Skin Diseases (Skin Disease) 10/2023 - 12/2017
3	Inclusion Body Myositis 01/2023 - 06/2016
3	Deglutition Disorders (Dysphagia) 01/2022 - 11/2017
3	Exanthema (Rash) 05/2021 - 07/2012
3	Rheumatoid Arthritis 01/2021 - 07/2008
3	Polymyositis 06/2016 - 09/2002
3	Arthritis (Polyarthritis) 08/2013 - 06/2009
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2023 - 11/2012
2	Muscle Weakness 05/2022 - 09/2010
2	COVID-19 01/2022 - 10/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2017
2	Pulmonary Hypertension 01/2021 - 01/2004
2	Lupus Nephritis 07/2019 - 12/2015
2	Multiple Sclerosis 10/2018 - 04/2010
2	Myalgia 12/2017 - 11/2017
2	Edema (Dropsy) 12/2017 - 11/2017
2	Fibrosis (Cirrhosis) 11/2017 - 10/2015
2	Inflammation (Inflammations) 11/2017 - 07/2011
2	Gangrene 01/2017 - 01/2016
2	Vascular Diseases (Vascular Disease) 10/2016 - 08/2009
2	Ulcer 05/2015 - 07/2014
2	Antisynthetase syndrome 08/2013 - 06/2009
1	Constipation 08/2023
1	Mediastinal Emphysema (Pneumomediastinum) 01/2023
1	Pneumothorax 01/2023
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Anemia 07/2019

Drug/Important Bio-Agent (IBA)

60	AutoantibodiesIBA 11/2023 - 07/2002
36	AntibodiesIBA 11/2023 - 09/2010
22	AutoantigensIBA 01/2023 - 07/2002
12	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2005
6	EnzymesIBA 01/2023 - 10/2018
5	InterferonsIBA 10/2023 - 10/2012
5	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 11/2012
5	RNA Polymerase IIIIBA 01/2019 - 09/2010
4	ImmunosorbentsIBA 01/2023 - 10/2018
4	RNA Polymerase I (Polymerase I, RNA)IBA 12/2022 - 09/2010
4	RNA (Ribonucleic Acid)IBA 12/2022 - 11/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2009
4	Signal Recognition ParticleIBA 01/2022 - 09/2010
4	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 09/2010
4	AntigensIBA 01/2016 - 02/2005
4	Granzymes (Granzyme)IBA 04/2010 - 07/2002
3	Coenzyme A (CoA)IBA 01/2023 - 01/2022
3	nuclear matrix protein 2IBA 01/2023 - 12/2017
3	IFIH1 Interferon-Induced HelicaseIBA 01/2023 - 07/2012
3	Immunoglobulin M (IgM)IBA 05/2022 - 10/2020
3	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 02/2021 - 09/2010
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 09/2010
2	Methylprednisolone FDA LinkGeneric 01/2023 - 05/2022
2	Mi-2 antibodiesIBA 01/2023 - 01/2022
2	UbiquitinIBA 01/2023 - 05/2021
2	AngiotensinsIBA 05/2022 - 10/2020
2	transcriptional intermediary factor 1IBA 01/2022 - 07/2014
2	tofacitinibIBA 01/2022 - 01/2021
2	Antinuclear AntibodiesIBA 01/2021 - 09/2015
2	Nucleosomes (Nucleosome)IBA 07/2019 - 10/2018
2	SS-A antibodiesIBA 01/2019 - 12/2015
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 10/2018 - 02/2011
2	Nuclear Matrix-Associated ProteinsIBA 10/2018 - 11/2013
2	anti-RNA-polymerase III autoantibodyIBA 01/2018 - 11/2015
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017 - 11/2012
2	Ligases (Synthetase)IBA 07/2011 - 09/2002
2	Transfer RNA (tRNA)IBA 07/2011 - 09/2002
2	NucleophosminIBA 01/2004 - 10/2003
1	Immunoglobulin IsotypesIBA 10/2023
1	Interferon Type IIBA 10/2023
1	gephyrinIBA 08/2023
1	sperm releasing substanceIBA 01/2023
1	Pattern Recognition ReceptorsIBA 01/2023
1	Nucleic AcidsIBA 01/2022
1	imidazole mustard (BIC)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	CortactinIBA 01/2022
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	HeterochromatinIBA 07/2019

Therapy/Procedure

5	Therapeutics 01/2018 - 09/2010
1	Immunomodulation 01/2023
1	Precision Medicine 12/2021